An accurate and precise representation of drug ingredients.

Journal: Journal of biomedical semantics
PMID:

Abstract

BACKGROUND: In previous work, we built the Drug Ontology (DrOn) to support comparative effectiveness research use cases. Here, we have updated our representation of ingredients to include both active ingredients (and their strengths) and excipients. Our update had three primary lines of work: 1) analysing and extracting excipients, 2) analysing and extracting strength information for active ingredients, and 3) representing the binding of active ingredients to cytochrome P450 isoenzymes as substrates and inhibitors of those enzymes.

Authors

  • Josh Hanna
    Biomedical Informatics Program, Department of Health Outcomes and Policy, University of Florida, Gainesville, FL USA.
  • Jiang Bian
    Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
  • William R Hogan
    Department of Health Outcomes and Biomedical Informatics.